IDEX BIOMETRICS ASA -ADR (IDBA) Stock Balance Sheet
NASDAQ:IDBA - Nasdaq - US45173W1053 - ADR - Currency: USD
| MRQ (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 7.38M | 16.12M | 33.76M | 7.30M | 14.13M | |||
| Receivables | 2.13M | 2.28M | 1.50M | 1.65M | 803.00K | |||
| Inventories | 5.32M | 4.45M | 1.23M | 859.00K | 686.00K | |||
| Other Current Assets | 1.96M | 986.00K | 851.00K | 1.03M | 770.00K | |||
| Total Current Assets | 16.80M | 23.84M | 37.35M | 10.84M | 16.39M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.50M | 2.65M | 1.66M | 2.68M | 3.39M | |||
| Goodwill | 968.00K | 968.00K | 968.00K | 968.00K | 941.00K | |||
| Intangibles | 1.37M | 1.49M | 1.97M | 2.44M | 2.60M | |||
| Other Non-Current Assets | -1.00K | N/A | N/A | N/A | 0.00 | |||
| Total Non-Current Assets | 4.90M | 5.18M | 4.68M | 6.17M | 7.08M | |||
| TOTAL ASSETS | 21.70M | 29.02M | 42.03M | 17.01M | 23.47M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 280.00K | 402.00K | 362.00K | 731.00K | 788.00K | |||
| Accrued Expenses | N/A | N/A | N/A | N/A | 3.00K | |||
| Accounts Payable | 1.05M | 1.54M | 685.00K | 631.00K | 463.00K | |||
| Other Current Liabilities | 3.13M | 3.09M | 3.24M | 2.80M | 3.76M | |||
| Total Current Liabilities | 4.46M | 5.03M | 4.29M | 4.17M | 5.02M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.25M | 1.14M | 11.00K | 327.00K | 610.00K | |||
| Deferred Taxes/Income | N/A | N/A | N/A | 0.00 | 31.00K | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 1.25M | 1.14M | 11.00K | 327.00K | 641.00K | |||
| TOTAL LIABILITIES | 5.71M | 6.17M | 4.30M | 4.49M | 5.66M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -310.64M | -303.40M | -1.24M | -14.69M | -198.18M | |||
| Additional Paid In Capital | 4.18M | 4.04M | 9.45M | 3.61M | 197.64M | |||
| Common Shares | 22.80M | 22.76M | 20.41M | 17.25M | 15.45M | |||
| Other Shareholders' Equity | 299.64M | 299.44M | 9.10M | 6.34M | 2.91M | |||
| Shares Outstanding | 17.57M | 17.53M | 15.19M | 12.51M | 10.79M | |||
| Tangible Book Value per Share | 0.01 | 0.02 | 0.03 | 0.01 | 0.02 | |||
| Total Shareholders' Equity | 15.98M | 22.84M | 37.73M | 12.51M | 17.81M | |||
| TOTAL LIABILITIES AND EQUITY | 21.70M | 29.02M | 42.03M | 17.01M | 23.47M | |||
| Statistics | ||||||||
| Debt/Equity | 0.08 | 0.05 | 0.00 | 0.03 | 0.03 | |||
| Current Ratio | 3.77 | 4.74 | 8.71 | 2.60 | 3.27 | |||
| Return On Assets (ROA) | -146.48% | -112.57% | -77.46% | -157.32% | -138.15% | |||
| Return On Equity (ROE) | -198.87% | -143.00% | -86.29% | -213.79% | -182.03% | |||
All data in USD , ROIC based on taxRate of 0.21